KDventures AB (2I9) Stock Price & Analysis
2I9 Stock Chart & Stats
- Day’s Range
- $0.00 - $0.04
- 52-Week Range
- $0.00 - $0.07
- Previous Close
- $0.04
- Volume
- N/A
- Average Volume (3M)
- 525
- Market Cap
- EUR 16.22M
- Enterprise Value
- EUR 114.66M
- Total Cash (Recent Filing)
- N/A
- Total Debt (Recent Filing)
- N/A
- Price to Earnings (P/E)
- ―
- Beta
- 56.31
- Next Earnings
- Nov 13, 2026 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
KDventures AB News
2I9 FAQ
What was KDventures AB’s price range in the past 12 months?
What is KDventures AB’s market cap?
When is KDventures AB’s upcoming earnings report date?
How were KDventures AB’s earnings last quarter?
Is KDventures AB overvalued?
Does KDventures AB pay dividends?
What is KDventures AB’s EPS estimate?
How many shares outstanding does KDventures AB have?
What happened to KDventures AB’s price movement after its last earnings report?
Which hedge fund is a major shareholder of KDventures AB?
What is the TipRanks Smart Score and how is it calculated?
Company Description
KDventures AB
Karolinska Development AB (publ) is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, healthcare technology, gene research and development, drug delivery technologies, biotechnology, and life science tools and service sectors. The firm seeks to invest in the Nordic region with a focus on Sweden, Iceland, Norway, Finland, and Denmark. It prefers to be a lead investor in its portfolio companies however does consider co-investments also. It seeks to invest in up to five projects annually. Karolinska Development AB (publ) was founded in 2003 and is headquartered in Stockholm, Sweden.
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Viktor Drvota M.D., Ph.D.
- Employees
- 8
- Website
- www.karolinskadevelopment.com
- Address
- Tomtebodavägen 23 A, Solna, 17165, SE






